Related Experiment Videos
Status epilepticus in immature rats. Protective effects of glucose on survival and brain development
Insights
Glucose pretreatment significantly reduces mortality and brain damage from status epilepticus (SE) in young rats. This protection is linked to glucose
Area of Science:
- Neuroscience
- Biochemistry
- Developmental Biology
Background:
- Status epilepticus (SE) is a neurological emergency with severe complications, particularly in developing brains.
- The metabolic demands and glucose utilization during SE in immature animals are not fully understood.
- Understanding glucose metabolism's role is crucial for developing effective treatments for SE complications.
Purpose of the Study:
- To investigate the role of glucose metabolism in mitigating the adverse effects of status epilepticus (SE) in developing rats.
- To determine if glucose supplementation can reduce mortality and brain damage associated with SE in young animals.
Main Methods:
- Developing rats of various ages were pretreated with glucose or saline before inducing status epilepticus.
- Mortality rates were recorded, and brain DNA synthesis was measured during seizures in 4-day-old rats.
- Brain weight, DNA, RNA, protein, and cholesterol content were assessed in survivors at 7 days of age.
Main Results:
- Glucose pretreatment dramatically reduced SE-induced mortality in rats under 20 days old, with greater efficacy in younger animals.
- Glucose treatment lessened reductions in brain DNA synthesis during seizures and preserved brain composition in survivors.
- In saline-treated rats, brain glucose levels fell during seizures without a drop in blood glucose, indicating impaired brain glucose uptake.
Conclusions:
- Brain glucose depletion can occur during SE in immature animals, even without systemic hypoglycemia, and is a treatable complication.
- Glucose's protective effects in SE appear to stem from its role as a carbon source rather than solely an energy substrate.
- Glucose supplementation is a promising therapeutic strategy for managing SE complications in developing individuals.
Abstract:
The role of glucose metabolism in alleviating the complications of status epilepticus (SE) was investigated in developing rats. Pretreatment with glucose reduced mortality from SE by 90% in rats under 1 week of age, 80% in 10-day-old rats, 50% in 15- to 20-day-olds, and not at all in adults. In 4-day-old animals, brain DNA synthesis during seizures, and in survivors, brain weight, DNA, RNA, protein, and cholesterol contents at 7 days of age were reduced less in glucose-treated than in saline-treated littermates. In the saline group, seizures caused a progressive fall in brain glucose level but no fall in blood glucose level, suggesting that glucose transport from blood to brain could not keep pace with glycolytic demands. In glucose-treated rats, blood and brain glucose concentrations remained elevated throughout the convulsive period. There was no reduction of brain adenosine triphosphate levels in either group. Thus, the protection by glucose appears to be related to its roles as a carbon source rather than an energy source. It is concluded that in immature animals, depletion of brain glucose can occur in the absence of hypoglycemia, and may be an important and potentially treatable complication of status epilepticus.